Skin cells coaxed into becoming eggs, then fertilized for the first time
In a laboratory in the United States, scientists have for the first time coaxed ordinary skin cells into becoming fertilizable eggs — a milestone that quietly reshapes what it means to be biologically unable to have children. Using a technique called mitomeiosis, researchers solved a chromosomal puzzle that had long blocked this path, producing 82 functional eggs and watching nine percent develop into early embryos. The work is far from clinical use, but it opens a door that, for millions facing infertility without viable options, had never existed before.
- For people who cannot produce healthy eggs or sperm — due to age, cancer treatment, or medical conditions — existing fertility treatments often reach a dead end, leaving donor genetics as the only path forward.
- Scientists cracked a decades-old biological barrier by developing mitomeiosis, a process that corrects the chromosome imbalance created when a skin cell nucleus is placed into a donor egg.
- Of 82 lab-grown eggs fertilized with sperm, nine percent reached the blastocyst stage — the threshold at which embryos are typically transferred during IVF — marking the first time this has been achieved in humans.
- Reproductive medicine experts are cautiously encouraged, calling it a meaningful proof of concept while stressing that significant safety testing must precede any clinical application.
- The research is still in its earliest stages — no lab-grown egg has developed beyond the blastocyst — but the technique could eventually transform infertility treatment and deepen understanding of miscarriage.
In a United States laboratory, researchers have done something that has never been done before: they took skin cells from a human body, transformed them into eggs, and successfully fertilized those eggs. The work is early and the road to clinical use is long, but the implications are profound.
The challenge the team had to solve was chromosomal. Most human cells carry 46 chromosomes, but reproductive cells need only 23. When a skin cell nucleus is transplanted into a donor egg, the resulting cell carries too many chromosomes — a problem that had stymied scientists for years. The team's solution was mitomeiosis, a laboratory process that mimics the natural division that discards the extra chromosomes, leaving a cell with the correct genetic load for fertilization.
Using this method, the researchers produced 82 functional egg cells from skin cells. After fertilization with sperm, nine percent developed to the blastocyst stage — the point, around six days after fertilization, at which cells begin dividing rapidly and embryos would normally be transferred during IVF. The researchers did not take the work further.
The significance lies in who this could one day help. Infertility is not always solvable by existing treatments. Some people cannot produce healthy eggs or sperm at all; others have lost theirs to cancer treatment or age. The field of in vitro gametogenesis — creating reproductive cells in the laboratory — offers the possibility of using a person's own genetic material when their body cannot.
Experts have responded with measured optimism. Professors at the universities of Southampton and Edinburgh both acknowledged the finding as a genuine proof of concept, while emphasizing that important safety questions must be answered before this moves from bench to bedside. No one yet knows whether these eggs could yield healthy pregnancies. But for those facing infertility with no other options, the research represents something new: a possibility where none existed before.
In a laboratory in the United States, researchers have taken skin cells from a human body and coaxed them into becoming eggs—then fertilized those eggs successfully. It is the first time this has been done. The work is early, the implications are vast, and the questions it raises are just beginning.
The technique rests on a biological sleight of hand. Normally, the body creates eggs and sperm through a process that halves the number of chromosomes—humans carry 46 in most cells, organized into 23 pairs, but reproductive cells need only 23. When scientists take a skin cell nucleus and implant it into a donor egg with its own nucleus removed, they end up with a cell carrying too many chromosomes: two full sets instead of one. For years, researchers knew how to do this part. What they did not know was how to fix the chromosome problem in human cells.
The team developed what they call mitomeiosis—a process that mimics the natural division that discards the extra chromosomes, leaving behind a cell with the right genetic load to be fertilized and develop. Using this method, they created 82 functional egg cells from skin cells. When they fertilized these eggs with sperm in the laboratory, nine percent of them progressed to the blastocyst stage, the point at which cells begin dividing rapidly around six days after fertilization. This is the stage at which embryos would normally be transferred into the uterus during IVF treatment. The researchers did not take the work beyond this point.
Why does this matter? Because infertility is not always a problem that existing treatments can solve. Some people cannot produce healthy eggs or sperm, and for them, IVF fails unless they use donor genetic material. Others have lost their eggs to cancer treatment or age. The emerging field of in vitro gametogenesis—the creation of egg or sperm-like cells in the laboratory—offers a different path: the possibility of using a person's own genetic material to create reproductive cells when their body cannot.
Experts in the field have greeted the finding with cautious enthusiasm. Ying Cheong, a professor of reproductive medicine at the University of Southampton, called it a proof of concept that skin cell DNA can be placed into an egg, activated, and made to halve its chromosomes in a way that mimics natural reproduction. He noted that clinicians increasingly encounter patients who cannot use their own eggs due to age or medical conditions, and that while this work is still very early, it could eventually transform how we understand infertility and miscarriage, and perhaps one day create reproductive options for people with no other choices.
Richard Anderson, a reproductive science professor at the University of Edinburgh, emphasized the potential for women who have lost their eggs—whether through cancer treatment or other causes. Generating new eggs from a person's own cells would be a major advance, he said. The study demonstrates that skin cell genetic material can produce an egg-like cell with the correct chromosome count to be fertilized and develop into an early embryo. But he also sounded a note of caution: there are very important safety concerns that will need to be addressed before this moves from the laboratory into clinical practice.
The work remains in its infancy. No one has yet taken these lab-grown eggs beyond the blastocyst stage. No one knows whether they could develop into healthy embryos, or whether a pregnancy could result. The path from proof of concept to a treatment available to patients is long and uncertain. But for people facing infertility with no viable options, the door that this research opens—however narrow, however distant—represents something that did not exist before: a possibility.
Notable Quotes
For the first time, scientists have shown that DNA from ordinary body cells can be placed into an egg, activated, and made to halve its chromosomes, mimicking the special steps that normally create eggs and sperm.— Ying Cheong, professor of reproductive medicine, University of Southampton
The ability to generate new eggs would be a major advance, and this study shows that the genetic material from skin cells can be used to generate an egg-like cell with the right number of chromosomes to be fertilised and develop into an early embryo.— Richard Anderson, professor of clinical reproductive science, University of Edinburgh
The Hearth Conversation Another angle on the story
What exactly is the barrier these scientists just cleared? Why couldn't this be done before?
The chromosome problem. When you take a skin cell nucleus and put it in an egg, you end up with too much genetic material—two full sets of chromosomes instead of one. Scientists knew how to do the transplant part. They just didn't know how to safely remove the extra chromosomes in human cells. This team figured out mitomeiosis—a way to trigger the cell to discard the excess, the way it naturally does during reproduction.
So they made 82 eggs. But only nine percent made it to the blastocyst stage. That sounds like a low success rate.
It is low. But remember, this is the first time anyone has done this with human cells at all. They're not comparing themselves to natural conception or even to standard IVF success rates. They're asking: can we do this at all? And the answer is yes. The next questions—how to improve the rate, whether these cells can develop further—those come next.
Who actually benefits from this, if it works?
People who can't make their own eggs or sperm. A woman who lost her eggs to cancer treatment. Someone whose age has made egg production unreliable. Anyone whose infertility stems from the body's inability to produce healthy reproductive cells. Right now, their only option is a donor. This could change that.
The experts mentioned safety concerns. What are they worried about?
They didn't specify, but the obvious ones: whether these lab-grown eggs could produce healthy embryos, whether pregnancies could result, whether there might be genetic or developmental problems. This is human reproduction. The stakes are high. You can't move from blastocyst to clinical use without being very sure it's safe.
How far away is this from being something a patient could actually use?
Years, probably. Maybe many years. This is proof of concept. It's important, but it's not treatment. There's a long road of testing and refinement ahead. But for people with no other options, knowing that road exists at all is significant.